Metal‐dependent regulated cell death: Molecular architecture and translational frontiers
iMeta · 2026-06 · 5 (3)
DOI: 10.1002/imt2.70141 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift iMeta, online erschienen am 06.07.2026. Verfasst von Haoliang Hu und 20 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology Zhejiang University School of Medicine Hangz…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 747 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Intracellular metal dyshomeostasis has emerged as a key regulator of specialized regulated cell death (RCD) programs, challenging classical views that regard necrosis as entirely accidental. This review systematically delineates the molecular architecture and translational trajectories underlying metal‐dependent RCD, including iron‐driven ferroptosis, copper‐mediated cuproptosis, and additional emerging modalities such as calcicoptosis, necrosis by sodium overload (NECSO), and the newly designated zincoptosis, mnoptosis, and coptosis. We examined distinct execution mechanisms, ranging from membrane lipid peroxidation and lipoylation‐targeted proteotoxic stress to organelle‐specific bioenergetic failure, which arise following disruption of compartmentalized metal‐buffering networks. To bridge the persistent knowledge gap between foundational metallobiology and clinical application, we evaluated a bidirectional therapeutic framework: exploiting synthetic lethality and metabolic gating via clinical inducers (e.g., sorafenib, elesclomol) to selectively eliminate therapy‐resistant malignancies while deploying targeted pathway inhibitors and systemic agonists (e.g., dipyridamole, omaveloxolone) to limit pathological tissue degeneration in ischemic and neurodegenerative disorders. Recognizing that off‐target multiorgan toxicity and complex in vivo crosstalk among interconnected death pathways (e.g., disulfidptosis and PANoptosis) represent major translational challenges, we assessed advanced materials‐science strategies designed to overcome these barriers. Specifically, we highlighted the integration of single‐atom catalysts, stimuli‐responsive nanomedicines, and biomimetic carriers engineered to spatiotemporally confine catalytic oxidative flux. Finally, we examined the systemic immunological consequences of targeted metal dysregulation, detailing how metal‐induced immunogenic cell death and cyclic GMP‐AMP synthase (cGAS)‐stimulator of interferon genes (STING) pathway hyperactivation reshape immunosuppressive microenvironments and modulate sterile inflammation, thereby enhancing responsiveness to immune checkpoint blockade, providing a definitive molecular blueprint for next‐generation precision therapeutics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Second Affiliated Hospital, School of Public Health, State Key Laboratory of Experimental Hematology Zhejiang University School of Medicine Hangzhou China.
- The Key Laboratory of Study and Discovery of Small Targeted Molecules of Hunan Province, School of Pharmaceutic Science, Health Science Center Hunan Normal University Changsha China.
- State Key Laboratory of Microbial Technology (Changde R&D Base), Institute of Synthetic Biology Industry Hunan University of Arts and Science Changde China.
- Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical College University of South China Hengyang China.
- The National and Local Joint Engineering Laboratory of Animal Peptide Drug Development, College of Life Sciences Hunan Normal University Changsha China.
- Peptide and Small Molecule Drug R&D Plateform, Furong Laboratory Hunan Normal University Changsha China.
ORCID-Profile: Haoliang Hu, Zhe Chen, Yaqi Li, Jiayi Peng, Hong Zhou, Meiqing Liu, Kerui Huang, Deguan Lv, Junxia Min, Linxi Chen, Fudi Wang
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Hu, H., Chen, Z., Li, Y., Peng, J., Cao, J., Zhou, H., Wang, M., Du, Y., Wu, H., Zhao, H., Huang, S., Yu, D., Liu, M., Shevchenko, O. V., Matveeva, N. Y., Yang, Y., Huang, K., Lv, D., Min, J., …, & Wang, F. (2026). Metal‐dependent regulated cell death: Molecular architecture and translational frontiers. iMeta, 5(3). https://doi.org/10.1002/imt2.70141
Vancouver
Hu H, Chen Z, Li Y, Peng J, Cao J, Zhou H, et al. Metal‐dependent regulated cell death: Molecular architecture and translational frontiers. iMeta. 2026;5(3). doi:10.1002/imt2.70141
BibTeX
@article{Hu2026,
author = {Hu, Haoliang and Chen, Zhe and Li, Yaqi and Peng, Jiayi and Cao, Jiangang and Zhou, Hong and Wang, Mengqi and Du, Yuejia and Wu, Hailin and Zhao, Huiqin and Huang, Shifang and Yu, Dianmei and Liu, Meiqing and Shevchenko, Olga V and Matveeva, Natalia Yu and Yang, Yiyuan and Huang, Kerui and Lv, Deguan and Min, Junxia and Chen, Linxi and Wang, Fudi},
title = {Metal‐dependent regulated cell death: Molecular architecture and translational frontiers},
journal = {iMeta},
year = {2026},
volume = {5},
number = {3},
doi = {10.1002/imt2.70141}
}
EUVIMED